Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR by unknown
ALLOGENEIC  INDUCTION  OF THE  HUMAN  T 
CELL-INSTRUCTED  MONOCYTE  PROCOAGULANT  RESPONSE 
IS  RAPID  AND  IS  ELICITED  BY HLA-DR* 
BY HEIKKI HELIN  ~ AND THOMAS S. EDGINGTON 
From the Department  of Immunology, Research Institute of Scripps Clinic, La Jolla, 
California  92037 
The allogeneic mixed lymphocyte culture (MLC) ~  system has been widely used 
as an in vitro model for analysis of lymphocyte recognition mechanisms and the 
coupled responses. After recognition of allogeneic B cells and monocytes, lym- 
phocytes undergo several phenotypic and functional changes, i.e., blast transfor- 
mation  and  proliferation  as  well as differentiation  to allospecific cytolytic and 
memory cells (reviewed in reference  1). The cellular locus of these well-recog- 
nized consequences of the recognition of allogeneic differences in molecules of 
the major histocompatibility complex is the T  lymphocyte. The effector functions 
of the cells of the mononuclear phagocyte series, the monocytes and macrophages 
induced by the aliogeneic response, have been less well delineated.  Newman et 
al. (2) reported the induction of plasminogen activator in monocytes by cell-free 
MLC supernatants,  and  several conflicting  results have been published on  the 
generation  of molecules able to initiate  the coagulation  protease cascade, e.g., 
procoagulant activity (PCA) of the tissue factor type in human allogeneic MLC 
(3-5). The first topic of controversy has been the inducibility of PCA per se in 
the  allogeneic  MLC:  whereas  Rickles et  al.  (3)  were  unable  to  observe  PCA 
generation,  Rothberger et al.  (4) and  van  Ginkei  et al.  (5)  demonstrated  such 
responses. 
The generation of procoagulant molecules by allogeneic stimulation is impor- 
tant to basic immunobiology because it is a poorly characterized effector mech- 
anism of the lymphoid system and because microvascular thrombosis and peri- 
vascular and interstitial  fibrin deposits are tissue lesions commonly encountered 
during rejection of human kidney and skin allografts (6, 7). We here explore the 
ability of human peripheral blood mononuclear cells (PBM) to recognize alloge- 
neic differences and respond by induction  of the monocyte PCA pathway. Our 
results demonstrate  a  relatively rapid procoagulant response that  is temporally 
dissociated from T  cell proliferation.  We present data to suggest that this is a T 
cell-instructed  activation  pathway  for  induction  of  monocyte  PCA  response 
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initiated by HLA-DR antigens and that it appears to be discordant with respect 
to proliferative allogeneic responses. 
Materials and  Methods 
Cell Isolations.  Venous blood was drawn from healthy volunteers into 5 U/ml (final) 
sodium heparin. PBM were isolated as previously described (10) on Ficoll-Hypaque density 
gradients followed by three washes in RPMI  1640 medium (Irvine Scientific, Santa Ana, 
CA) containing 2 mM L-Glutamine, 25 mM Hepes, and 50 ~g/ml gentamycin. PBM were 
>94% viable by" trypan blue exclusion and contained <2% polymorphonuclear leukocytes. 
Monocytes were isolated on the basis of their receptor-mediated attachment to fibro- 
nectin on gelatin-coated surfaces (8,  9) as described in detail elsewhere (10).  The mono- 
cytes used in reconstitution experiments were ___97% nonspecific esterase positive (11) and 
>90% excluded trypan blue. 
Nylon wool columns (12) were used to isolate T  cells from nonadherent lymphocytes 
recovered from gelatin-fibronectin surfaces. When 0.5 g of nylon wool (Fenwal Labora- 
tories,  Deerfield,  IL  l  was  packed  into  12-ml  disposable  plastic  syringes  and  used  to 
fractionate 3-6 ×  10  cells,  ->94% of the nylon wool effluent cells reacted with OKT 11 
(Ortho Diagnostic Systems Inc., Westwood MA), a monoclonal antibody against human E 
rosette-forming  T  lymphocytes  (13).  In  some  experiments,  gelatin-fibronectin  non- 
adherent cells were depleted of monocytes by Sephadex G-10 gel filtration (14) in which 
8 ml of swollen gel was packed into  12-ml disposable plastic syringes over a glass wool 
layer; then 25-50 ×  106 cells were passed through such columns. The effluent cells were 
_>98% nonspeciflc esterase negative. 
Mixed Lymphocyte Culture.  MLC for analysis in the PCA pathway were carried out in 
12 ×  75-ram polypropylene tissue culture tubes (Falcon Labware, Oxnard, CA). Primary 
two-way allogeneic MLC were established in duplicate between  106 PBM from pairs of 
individual donors in 1.0 ml of either Leibovitz's L-15 medium supplemented with 2 mM 
e-glutamine, 50 #g gentamycin, and  10% heat-inactivated fetal calf serum (Irvine Scien- 
tific) or RPMI 1640 medium containing the same supplements plus 25 mM Hepes. Control 
cultures consisted of 106 PBM from single donors in 0.5 ml of the culture medium. In 
some MLC, cells from an established lymphoma B cell line, Daudi, were used to stimulate 
PBM. 106 Daudi cells were cultured with 106 PBM in !.0 ml of RPMI ! 640 medium after 
treatment of the Daudi cells with mitomycin C at 100 #g/ml for 25 rain at 37 °  C, followed 
by three washes in RPMI 1640. The MLC were incubated for varying times in a humidified 
atmosphere of 5% CO2, 95% air. 
To assess the proliferative response, the MLC were performed in 96-well flat-bottomed 
tissue  culture  plates  (Corning  Glass  Works,  Corning,  NY).  2  ×  105  PBM  from each 
individual  of pairs  of donors  were  cultured  in  triplicate  in  0.2  ml  of L-15  medium 
supplemented as described above. The cultures were harvested daily during a 7-d period, 
or after other time intervals as given in Results. The cells were cultured for 18 h in the 
presence of 1 #Ci/well of [SH]thymidine ([SH]TdR) before harvesting on glass fiber filters 
with an automated harvester. The filters were washed, dried,  placed in scintillant, and 
counted in a Beckman liquid scintillation counter (Beckman Instruments, Inc., Palo Alto, 
CA). 
Assay  for PCA.  The PCA content of the cells was assayed by their ability to accelerate 
the spontaneous clotting time of pooled, citrated platelet-poor, normal human plasma in 
a one-stage clotting assay (15). To analyze total PCA content, the cells were washed once 
after termination of the MLC, resuspended in serum-free RPMI  1640, and subjected to 
homogenization by three  cycles of freezing-thawing and  two cycles of sonication.  Cell 
lysates from single-donor control cultures were tested for PCA either separately or after 
combining the lysates, without any difference in the final results. PCA expression by. intact 
viable cells was determined on washed and resuspended cells without homogemzation. In 
the coagulation assay 100 #1 of cell suspension or homogenate and 100 #1 of 25 mM CaCi~ 
were added to 100 #1 of normal human plasma. The clotting time, from addition of CaCl~ 
to formation of a visible clot, was measured in glass tubes with constant rocking at 37°C. 964  ALLOGENEIC  INDUCTION  OF  MONOCYTE  PROCOAGULANT  ACTIVITY 
The times were converted to milliunits of PCA by reference to a standard curve derived 
from rabbit brain thromboplastin standard (Difco Laboratories, Inc. Detroit, MI) at 37.5 
mg dry weight/ml, which was assigned a value of 10  s mU/ml. Serial dilutions were used 
to produce a log-log plot. For further comparison, a 103 mU PCA/ml sample corresponds 
to a clotting time of ~50 s. 
In some clotting assays, human plasmas deficient in clotting factors VIII, IX, X (George 
King Bio-Medical,  Inc.,  Overland  Park,  KS),  or  in  factor VII  (from  Dr.  Daryl  Fair, 
Research Institute of Scripps Clinic),  were used as substrates instead of normal human 
plasma. Functional cleavage of prothrombin was assayed as described earlier (16) with a 
mixture of purified prothrombin (Dr. Daryl Fair) and purified fibrinogen (Dr. Ed Plow, 
Research Institute of Scripps Clinic) as substrate. 
Monoclonal Antibodies.  The mouse monoclonal antibodies SG 157 (a generous gift from 
Dr. Sanna Goyert and Dr. Jack Silver, Michigan State University, East Lansing) and OKIal 
(Ortho Diagnostic Systems, Inc.) to common determinants of HLA-DR have been de- 
scribed previously (17,  18). The antibodies were added to the MLC at the initiation of 
cultures. The mouse monoclonai antibody Leu 2a against human suppressor/cytotoxic T 
ceils (19) was purchased from Becton, Dickinson & Co., Sunnyvale, CA. 
Endotoxin Contamination.  All chemical reagents, monoclonal antibodies, tissue culture 
media, and fetal calf sera used were tested for endotoxin contamination by the limulus 
amoebocyte lysate assay (E-toxate; Sigma Chemical Co., St. Louis, MO) and were negative 
at the level of 0.1  ng/ml. 
Results 
Induction of PCA in MLC.  A total of 31 different cellular combinations in two- 
way MLC were established from 22 individuals and were analyzed for induction 
of monocyte PCA.  In  MLC harvested after 48 h  and assayed for total cellular 
PCA, all allogeneic pairs developed a  response in which the cellular PCA was at 
least  two  times  higher  than  that  of the  autologous  controls.  In  Table  I  the 
distribution  of the  response  levels for the  31  MLC combinations are given as 
relative degrees of stimulation (stimulation index). Five of the six donor combi- 
nations tested for PCA expression by intact viable cells demonstrated at least a 
twofold PCA response relative to control. 
Table II gives the mean PCA in MLC and control autologous cultures from 
15 donor pairs after 48 h  incubation in RPMI  1640 medium.  In MLC, a  PCA 
response approximately five times higher (~ =  5.3  ±  2.1, range 2.1-13.2) than 
that in controls was observed.  For comparison, after a  4-h  incubation with  10 
#g/ml  of bacterial  iipopolysaccharide  (LPS),  a  model  stimulus  for  monocyte 
PCA,  PBM responded with a  PCA of 736 ±  168 mU/106 cells (mean ±  SD of 
six experiments).  In  these experiments,  the relative degree of stimulation  was 
16.3 ±  4.1. 
TABLE  I 
Induction of Monocyte PCA in Two-Way  MLC:* Rate of Stimulation in 31 Allogeneic 
Combinations 
Stimulation index* 
1-3  3-6  6-9  9-12 
Number of allogeneic  9  11  8  3 
combinations 
* MLC in L-15 or RPMI 1640 medium were assayed at 48 h for total cellular PCA. 
Stimulation index --- [(PCA Donor A + Donor B)/(PCA Donor A + PCA Donor B)]. HELIN  AND  EDGINGTON 
TABLE  II 
Induction of Monocyte Procoagutant Actitivy in Two-Way Allogeneic MLC 
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Cell culture* 
Viable expression*  Total cell content  B 
PCA  Stimulation  PCA  Stimulation in- 
(mU/106 cells)  index  (mU/10  ~ cells)  dex ! 
Autologous  10 +  3  --  32  +  11  -- 
Allogeneic  30 _+ 15  3.8 + 2.3  174 _  113  5.3 ± 2.1 
*  48-h culture of 108 PBM from each donor in complete RPMI 1640 medium. 
* Mean + SD from 6 experiments. 
| Mean _+ SD from 15 experiments. 
t Stimulation  index calculated  as in legend to Table I. 
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FIGURE 1.  Temporal dissociation of monocyte PCA response (O) (autologous control culture 
[0]) and T cell proliferation (A) (autologous control culture [A]) in two-way allogeneic MLC. 
To assess PCA induction,  MLC were established  between  10  6 PBM from 10 pairs of donors 
in 1.0 ml of L-15 medium and, after incubation,  the cells assayed for total cellular PCA. For 
T cell proliferative  response,  2 x  10  5 PBM from each individual of the same pairs of donors 
were cultured in 0.2 ml of L-15 medium.  T  cell response  was assessed by [SH]TdR incorpo- 
ration. 
Time Course of  PCA Induction.  To assess the temporal profile of PCA induction, 
MLC  pairs  were  harvested  daily  and  assayed  for total  cellular  PCA as well  as 
PCA expression by intact cells. The PCA responses differed somewhat depending 
on the cell culture  conditions  used.  In Leibovitz's L-15 medium,  maximal  PCA 
generation  occurred  on  day  3  (Fig.  1),  showing an  almost  ninefold  increase  of 
activity from the initiation  of the culture.  In RPMI  1640 medium, the induction 
of PCA was greater  than  in  Leibovitz's L-15 medium  (Fig.  2, bottom). After 4  d 
of culture  the  PCA reached  a  maximum  20-fold  greater  than  the  initial  basal 
activity on day zero. When the PCA generated in MLC is compared with that in 
control autologous culture, a  relatively sharp peak of maximal activity is seen on 
day  2  (Fig.  2,  top). The  viable  PCA  was  maximally  expressed  on  day  6  by 
reference to the stimulation  index or on day 7  by reference to net PCA level. 
Lack of Concordance Between PCA Generation and [SH]TdR Uptake.  It is readily 
apparent from data illustrated  in Fig.  1 that in two-way ailogeneic MLC the PCA 
response and the  T  cell proliferative  response as measured  by [3H]TdR uptake 966  ALLOGENEIC  INDUCTION  OF  MONOCYTE  PROCOAGULANT  ACTIVITY 
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FIGURE 2.  Temporal profile of PCA induction in two-way allogeneic MLC. (Bottom) After 
incubation in RPMI  1640  medium, the cultures were assayed for total cellular (allogeneic 
[O], control [Q]) (nine donor combinations) or cell surface-expressed PCA (allogeneic [A], 
control [A]) (six donor combinations). Results are given as net PCA/106 cells. (Top) Responses 
for total cellular PCA (lq) and viable cell PCA expression (B) are given as stimulation indices, 
calculated as: [(PCA donor A + donor B)/(PCA donor A + PCA donor B)]. 
TABLE  III 
Allogeneic Induction of Cellular PCA Using Daudi Lymphoblastoid B Cells 
PCA*  Stimulation 
Culture*  (mU/106 PBM)  index 
Allogeneic (PBM + Daudi)  285 +  158  9.8 _  4.3 
Control (PBM, Daudi)  30 ___ 11  -- 
* Cultivation for 24 h in complete medium of 106 PBM, mixed with 106 mitomycin C-treated Daudi 
in 1 ml for allogeneic culture, then assayed for PCA. For control cultures, 106 PBM were separately 
cultured in 0.5 ml medium, and 106 mitomycin C-treated Daudi cells were separately cultured in 
0.5 ml medium. Each was assayed separately for PCA and the values were summed. 
* Mean -4- SD of experiments (six cell donors). 
were temporally dissociated. In a series of experiments consisting of 12 allogeneic 
MLC,  linear regression  analysis (detailed data  not  included)  with  a  correlation 
coefficient  (r)  of  0.068  indicated  a  lack  of  concordance  between  the  PCA 
responses on day 3 and the [~H]TdR uptake on day 7. The analysis was performed 
using both net PCA generated  and stimulation indices. 
Induction of PCA by Allogeneic Lymphoblastoid B Cells.  The  stimulatory capacity 
9f Daudi cells was analyzed in one-way MLC with allogeneic PBM as responding 
cells. When the MLC were established at a Daudi/PBM  ratio of 1 : 1 and incubated 
for  24  h,  the  PBM  gave a  10-fold PCA  response relative to autologous control 
culture (Table III). The  time course of PCA generation for  106 PBM stimulated 
by 106 Daudi cells is characterized in Fig. 3. By 6  h  a  readily measurable increase HELIN  AND  EDGINGTON  967 
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FIGURE 3.  Time  course  of  PCA  induction  in  one-way allogeneic  MLC.  Cultures  were 
established between 106  PBM and  106 mitomycin C-treated Daudi cells in  1.0  ml of RPMI 
1640.  Total  cellular  PCA  (mean  -+  SD  of three  experiments) for  MLC  (O)  and  control 
autologous cultures (O) were determined. 
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FIGURE 4.  Stimulatory capacity of Daudi lymphoblastoid B cells in PCA generation using 
one-way MLC.  Increasing numbers of mitomycin C-treated Daudi cells were added to  100 
allogeneic PBM, the cell mixtures incubated for 24 h and assayed for total cellular PCA. The 
maximal stimulation by 2  x  106 Daudi corresponds to a  Daudi/monocyte ratio of approxi- 
mately 8:1. 
of PCA from the basal activity was observed. Full PCA of --400 mU/106 PBM 
was  reached  in  18  h.  The  activity  remained  relatively  high  through  day  3, 
followed by a decline to control levels on day 7. A dose-response study consisting 
of four experiments  is  illustrated  in  Fig.  4.  Increasing  amounts  of Daudi cells 
were cultured for 24 h with a constant number of PBM, and the PCA determined 
on  cell  lysates.  An  input  of 2  x  10 6  Daudi  cells stimulated  the  highest  PCA 
response  in  106  PBM,  corresponding  to  a  Daudi/monocyte  ratio  of approxi- 968  ALLOGENE1C INDUCTION OF  MONOCYTE PROCOAGULANT ACTIVITY 
mately 8:1. 
Cellular Locus of PCA Induced in Allogeneic MLC.  To determine the cell type 
responsible for PCA generation, allogeneic MLC (PBM) were fractionated after 
48 h culture into fibronectin-adherent monocytes and monocyte-depleted (Seph- 
adex G-10 filtration) nonadherent lymphocyte  populations. These fractions were 
then assayed for total cellular PCA. Adherent monocytes contained ! 79  _+  29 
mU PCA/106 cells compared with 8.5 +  1.5 mU PCA/106 cells for the lympho- 
cyte-enriched fraction. In further experiments, MLC were established between 
Daudi cells and T  cell-reconstituted monocytes (Daudi/monocyte/T cell  ratio, 
2:1:4)  and  after  24  h  coculture,  the  cells  were  fractionated  into  adherent 
monocytes and monocyte-depleted nonadherent cells. The PCA response in the 
former was 1,140  _+ 209 mU/106 cells and 44 _+ 2 mU/106 cells in the latter. 
The vast majority of the PCA generated in MLC is thus produced by monocytes, 
consistent with the previous direct cytologic proof of the  monocyte origin of 
PCA for bacterial lipopolysaccharide- and immune complex-stimulated PBM (15, 
20,  21),  with only negligible levels in lymphocytes or Daudi lymphoblastoid B 
cells. 
Inhibition of the Allogeneically  Induced PCA by Monoclonal Anti-HLA-DR Antibod- 
ies.  To evaluate the role of HLA-DR (human Ia-like) antigens in the process of 
monocyte stimulation and  consequent  expression  of procoagulant  molecules, 
mouse monoclonal antibodies SG  157  and OKIal to common determinants of 
human HLA-DR were added to two-way MLC at the initiation of cultures. Both 
antibodies were able to inhibit 100% of the MLC-generated PCA response using 
106 PBM from two individual donors (Fig. 5). The dose-response curve exhibited 
a narrow plateau of complete inhibition followed at higher antibody concentra- 
tions by lower degree of inhibition (Fig. 5). The latter phenomenon is probably 
explainable by trace contamination with bacterial endotoxin in the monoclonal 
antibodies. Both antibodies gave a weakly positive reaction in limulus assay for 
25110"4  $x10-4  10-4  2xlO  "3  4zlO"~ 16x10-1 txlO 4  4xlO  4 
ANIIBODY DILUTION 
FmuRr  5,  Effect of hybridoma monoclonal-derived  antibodies to HLA-DR (OK 1a1 and SG- 
157) as well as control Leu-2 anti-T cell antibody  on PCA generation in two-way  allogeneic 
MLC. MLC were established between 106 PBM from pairs of donors and the antibodies  added 
at the initiation of the 48-h cultures, after which the cells were assayed for total PCA. For 
comparison of the three antibodies, the total protein contents  in the ascites fluids  are given  at 
the highest  concentrations  used. HELIN  AND  EDGINGTON  969 
bacterial endotoxin at the highest concentrations used in the blocking experi- 
ments. The use of an irrelevant control monoclonai antibody, Leu 2a, that was 
negative for bacterial endotoxin at all concentrations, had no effect on the PCA 
response (Fig. 5). 
T  Cell Dependence  of  the  Allogeneic  Induction  of Monocyte Procoagulant  Re- 
sponse.  Cellular requirements for the allogeneic procoagluant response of mon- 
ocytes were assessed in one-way MLC between Daudi cells and unfractionated 
PBM, either purified monocytes (>97% nonspecific esterase positive) or mono- 
cytes reconstituted with nylon wool effluent T  cells. After 24 h the cultures were 
assayed for PCA generation. Allogeneic stimulation of purified monocytes re- 
sulted in a mimimal increase of PCA that was marginally above the control level 
(Fig. 6). A response comparable to that in unfractionated PBM was restored by 
reconstitution of 0.5  ×  106  monocytes with  2  ×  106 syngeneic T  cells before 
starting the MLC. 
Characterization of the Procoagulant Activity Induced in Allogeneic MLC.  To ex- 
amine functional characteristics of the procoagulant effector molecule produced 
by the monocyte and expressed on  its surface, one-stage clotting assays were 
performed using plasma substrates selectively deficient in single known coagu- 
lation proteins. Lysates of alloactivated cells initiated full coagulation activity in 
plasmas deficient in factors VIII and IX of the intrinsic pathway (Table IV). The 
cells were unable to fully accelerate the coagulation rate of plasmas deficient in 
factors VII  or  X.  Reconstitution  with  purified factor  VII  or  X  restored the 
procoagulant effect of the cells, indicating a requirement for these coagulation 
proteins. 
The  MLC  homogenates did  not  induce  clotting  in  a  mixture  of purified 
prothrombin and fibrinogen, ruling out the participation of prothrombinase-like 
activity  described  in  certain  other  T  cell-dependent  pathways  of  monocyte 
procoagulant induction (16, 20, 22). These results with MLC-induced PCA are 
characteristic of tissue factor expression by monocytes and were comparable to 
the initiation of coagulation using a rabbit brain thromboplastin preparation as 
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FIGURE 6.  T  cell requirement for optimal PCA response in one-way allogeneic MLC.  108 
Daudi cells were used to stimulate 10  ° unfractionated PBM (D/PBM) and 0.5 x  106 purified 
monocytes either alone (D/Mo) or after reconstitution with 2  x  l0  s T  cells (D/Mo +  T). 
Similarly,  2  x  106 T  ceils were stimulated with  10  s Daudi cells (D/T).  The cultures were 
incubated for 24 h and assayed for total cellular PCA. Results given are the mean +  SD from 
six experiments.  Shaded portions of the bars are controls obtained by summation of PCA 
values from participants of MLC cultured separately. 970  ALLOGENEIC  INDUCTION  OF  MONOCYTE  PROCOAGULANT  ACTIVITY 
TABLE  IV 
Requirements of AllogeneicaUy Induced Monocyte PCA for Known Coagulation Proteins 
PCA assay in various substrate plasmas (clotting time, seconds) 
Test sample  VIll deft-  VII deft- 
NHP*  X deficient  IX deficient  cient  cient 
Allogeneic culture  54  337  62  55  158 
lysate 
Medium  203  >450  >450  >450  217 
Thromboplastin  37  429  40  36  164 
* Normal human plasma. 
a source of tissue factor (Table IV). 
Discussion 
Monocyte PCA represents an inducible effector mechanism that has its molec- 
ular basis in  the expression of cell  membrane-associated  tissue factor (23) or a 
recently described cellular serine protease that  directly cleaves prothrombin  to 
functional  thrombin  (16,  22).  The  synthesis  and  cell  surface  expression  by 
monocytes and macrophages of effector molecules able to initiate the coagulation 
pathways can  be induced  by a  variety of stimuli.  These include  bacterial  LPS 
(24, 25), antigen-antibody complexes (21,  26), soluble protein antigens in pre- 
sensitized individuals (27), and mouse hepatitis virus in responsive mouse strains 
(28). 
The present study demonstrates that alloantigens are relatively potent inducers 
of monocyte PCA in MLC. 71% of 31  donor combinations analyzed in two-way 
cultures  exhibited at  least threefold  responses relative  to controls.  When  cells 
from a  lymphoblastoid B  cell line,  Daudi,  were used as a  source of allogeneic 
stimulus, the mean relative degree of response was twice that for two-way MLC 
using  PBM  from  pairs  of individual  donors.  Daudi  cells,  which  express  only 
negligible amounts of basal or inducible PCA, are useful as a model stimulus to 
investigate the allogeneic PCA response. 
The  temporal  characteristics  of the induction  of monocyte tissue factor, the 
procoagulant effector molecule implicated in the allogeneic response, are unique 
relative to previously described lymphoid procoagulant responses. In contrast to 
the  4-h  maxima  observed  for  immune  complexes  (21),  endotoxin  (15),  and 
murine  hepatitis  virus  (18),  the  two-way allogeneic  response  required  2-3  d. 
This induction  is,  however, rapid for allogeneic responses, as demonstrated by 
comparison  with  T  cell  proliferation  in  the  same  MLC.  Daudi-stimulated  re- 
sponses were even more prompt, reaching maxima within  18 h. 
Few studies of the allogeneic induction of lymphoid PCA have been described. 
Rickles et al.  (3),  performing  MLC with  cells from four donors and assays for 
PCA  after  24,  48,  and  72  h,  were  unable  to  observe  the  PCA  response. 
Rothberger et ai.  (4) subsequently observed enhancement  of tissue factor type 
cellular  PCA  in  allogeneic cultures.  Maximal  PCA  relative  to control  was ob- 
served after 7 d of culture. In these experiments both the MLC and the control 
autologous cultures produced significant increments of PCA as early as day one, HELIN  AND  EDGINGTON  971 
a result attributed to factors in serum-supplemented tissue culture media. Such 
an activation, also consistent with endotoxin contamination, which is relatively 
ubiquitous in commercially available sera and media, would have obscured early 
increases of PCA due to allogeneic stimulation. Van Ginkel et al. (5) confirmed 
the induction of tissue factor expression in MLC harvested on day seven but give 
no information on the temporal course of induction of PCA. 
Induction of monocyte PCA response only after 7 d for full activity is remark- 
ably  slow  and  sharply  contrasts  with  other  known  monocyte PCA-induction 
pathways, which usually result in  maximal activity within 4-6  h  (20,  29,  30). 
This suggests that the cellular pathway and metabolic requirements may differ 
significantly from those so far described. The apparent discrepancies between 
the present study and prior results in which either no response was observed or 
it  occurred only  relatively late  may  in  part  be  influenced by  differences in 
methodology. The lower basal or control levels of PCA in our studies clearly 
permit identification of significant stimulation earlier during the response. Mon- 
ocyte activation by alloantigens and resultant procoagulant expression also may 
be dependent on experimental conditions similar to differences described for 
the T  cell proliferative response in MLC (31). The temporal dissociatioh and the 
lack of quantitative correlation between allogeneic induction of monocyte PCA 
and T  cell proliferation are not surprising in view of the different responding 
cells. There may also be differences in the allogeneic molecules that are recog- 
nized, the required cellular interactions, and the signals and their mode of action. 
The PCA response resulting from allogeneic stimulation was blocked by the 
addition of monoclonal antibodies to  HLA-DR antigens. Similarly, the use of 
polyclonal alioantisera (32) or xenoantisera (33, 34) or monoclonal xenoantisera 
(35-37) has resulted in various degrees of inhibition of T  cell proliferation in 
human allogeneic MLC.  These  results  have been  interpreted  to  indicate  the 
blocking of stimulatory epitopes  on  DR  (Ia-like) molecules on  the stimulator 
cells, i.e., B cells and monocytes. The same locus of blocking by monoclonal anti- 
DR antibodies is also possible in our experiments. The relative ease of complete 
blocking would suggest a  major role  for DR,  and as such,  provides  the first 
evidence for specificity in  the allogeneic PCA response.  Antigens encoded by 
other locuses are either not stimulatory, or the resulting stimulation is below the 
limit of detection in our system. Another possible target of blocking with anti- 
DR could be the T  cell collaboration with the effector monocyte, shown in the 
present  report  to  exist  for  the  MLC-induced procoagulant  response.  In  the 
mouse, the T  cells and monocytes required for full PCA response after stimula- 
tion  with  LPS  must  be  compatible  only at  the  I-A  subregion  of the  major 
histocompatibility complex (38). Whether this same requirement pertains to this 
response to allogeneic stimuli in the human is a topic of current investigation. 
In the present study the direct requirement for T cells is demonstrated for the 
first  time.  This  is  a  reasonable  expectation,  since  it  would  not  be  readily 
anticipated that allogeneic signals would directly induce the monocyte. The low 
PCA responses of purified monocytes to allogeneic stimulation demonstrate that 
only small amounts of PCA can be generated via such a direct pathway or that a 
slight contamination of responding monocytes with T  cells is able to support a 
suboptimal  PCA  response.  A  T  cell  requirement for optima]  monocyte PCA 972  ALLOGENEIC  INDUCTION  OF  MONOCYTE  PROCOAGULANT ACTIVITY 
response has been demonstrated for a variety of responses (reviewed in reference 
20) and is consistent with the general hypothesis for this pathway that T  cells 
serve as the recognition unit and the monocyte or macrophage as the effector 
unit. 
The alloantigenic stimulation of monocytes resulting in enhanced expression 
of procoagulant molecules may represent an important link between the immune 
system and the coagulation pathways, the former being responsible for recogni- 
tion and the latter  for effector function.  In clinical transplantation,  the tissue 
lesions of the predominantly vascular (humoral) type of renal allograft rejection 
often display extensive vascular thrombosis and deposition of fibrin at perivas- 
cular locations (6).  Circulating blood monocytes or tissue-bound mononuclear 
phagocytes, described as major constituents of cellular infiltrates in rejected renal 
allografts (39),  may have a  role in these clotting processes through allogeneic 
activation  of their  procoagulant  pathways.  This  concept is  supported  by  the 
findings of Hattler et al. (40) who evaluated the PCA in mononuclear blood cells 
recovered from a  rejected renal allograft and demonstrated PCA significantly 
higher than that in corresponding cells in the peripheral blood. In their recent 
report, I~alloran et al. (41) observed elevated PCA levels in PBM in patients with 
rejecting renal transplants.  In addition, in rejected first-set skin allotransplants, 
intravascular thrombosis has been a  common event according to some studies, 
such as by Henry et al.  (7).  In a  more recent report,  Dvorak et al.  (42)  have 
described a less frequent occurrence of thrombotic phenomena but, nevertheless, 
suggest a  contribution  of this mechanism to  infarction  of allografts.  In  these 
studies,  vascular  alterations  in  skin  transplants  were  accompanied  by  dermal 
fibrin accumulation. 
Summary 
The recognition of alloantigens by human lymphoid cells initiates a  collabo- 
rative cellular pathway that rather rapidly induces in adherent cells (monocytes) 
the synthesis and expression of cell surface tissue factor, the initiating cofactor 
of the extrinsic  coagulation  pathway.  This response was  vigorous,  generating 
tissue factor to a level nearly comparable to the response to endotoxin. However, 
it was temporally discordant with characterized lymphoid procoagulant responses 
to endotoxin, virus, and immune complexes in that it reached a maxima at 48 h, 
well after these other responses but clearly much faster than the well recognized 
proliferative responses to allogeneic stimulation. Using the Daudi lymphoblastoid 
B cell line, the allogeneic response could be fully elicited in a  dose-dependent 
fashion within  18 h. The induction of monocyte tissue factor required collabo- 
ration with T  lymphocytes, in accord with previously described T  ceil-instructed 
monocyte responses.  HLA-DR  was  implicated as  the  allogeneic signal  by  the 
ability of two monoclonal antibodies to completely block, in a  dose-dependent 
fashion,  the  induction  of this  pathway.  Notably,  the  allogeneic procoagulant 
response was quantitatively discordant with respect to the allogeneic proliferative 
response, suggesting differences in specificity. 
This relatively rapid response may be applicable to typing of determinants in 
the  major  histocompatibility  complex  that  are  not  equivalently  identified  by 
alternative analyses, and may be significant in tissue transplantation. The cellular HELIN  AND  EDGINGTON  973 
pathway, linking allogeneic recognition with induction of a  monocyte response 
that initiates the coagulation pathway, represents a further example of the linkage 
between  these  biologic  systems, and  is  consistent  with a  pathogenetic role  in 
ailograft rejection by the promotion of vascular thrombosis and interstitial fibrin 
accumulation. 
We thank Ellen Schmeding for preparation of this manuscript. 
Received  for publication 2 May 1983. 
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